prompt string | task_type string | answer list | data_source string |
|---|---|---|---|
Please answer the following multiple-choice question:
Question: Consider the following argument: 'The objective response rate was 26% (95% confidence interval [CI], 18.2% to 34.4%), with seven complete and 23 partial responses. Single-agent trastuzumab is active and well tolerated as first-line treatment of women with ... | 1C-P | [
"The most common treatment-related adverse events were chills (25% of patients), asthenia (23%), fever (22%), pain (18%), and nausea (14%).",
"Cardiac dysfunction occurred in two patients (2%); both had histories of cardiac disease and did not require additional intervention after discontinuation of trastuzumab."... | ABstRACT |
Please answer the following multiple-choice question:
Question: Consider the following argument: 'In this small study, CDB-2914 was well-tolerated without serious adverse events. Thus, there may be a role for CDB-2914 in the treatment of leiomyomata. No serious adverse events were reported. In this small study, CDB-291... | 1C-P | [
"In this small study, CDB-2914 was well-tolerated without serious adverse events.",
"CDB-2914 treatment resulted in improvements in the concern subscale of the Uterine Fibroid Symptom Quality of Life assessment."
] | ABstRACT |
Please answer the following multiple-choice question:
Question: Consider the following argument: 'In this small study, CDB-2914 was well-tolerated without serious adverse events. Thus, there may be a role for CDB-2914 in the treatment of leiomyomata. No serious adverse events were reported. In this small study, CDB-291... | 1C-P | [
"In this small study, CDB-2914 was well-tolerated without serious adverse events.",
"Compared with PLC, CDB-2914 significantly reduced leiomyoma volume after three cycles, or 90-102 days."
] | ABstRACT |
Please answer the following multiple-choice question:
Question: Consider the following argument: 'In this small study, CDB-2914 was well-tolerated without serious adverse events. Thus, there may be a role for CDB-2914 in the treatment of leiomyomata. No serious adverse events were reported. In this small study, CDB-291... | 1C-P | [
"CDB-2914 treatment resulted in improvements in the concern subscale of the Uterine Fibroid Symptom Quality of Life assessment.",
"Compared with PLC, CDB-2914 significantly reduced leiomyoma volume after three cycles, or 90-102 days."
] | ABstRACT |
Please answer the following multiple-choice question:
Question: Consider the following argument: 'Both bimatoprost and the timolol-dorzolamide combination were well tolerated. Bimatoprost can be used as a longterm monotherapy agent in the treatment of POAG and ocular hypertension. The IOP-lowering efficacies of bimatop... | 1C-P | [
"Both bimatoprost and the timolol-dorzolamide combination were well tolerated.",
"The IOP-lowering efficacies of bimatoprost and timolol-dorzolamide combination were similar over a 6-month follow-up."
] | ABstRACT |
Please answer the following multiple-choice question:
Question: Consider the following argument: 'Gender-based differences appear to play a role in the early, but not late, response to a multidisciplinary intervention to improve QOL for patients with advanced cancer, early interventions can be tailored for each gender.... | 1C-P | [
"Men receiving the intervention had a smaller decrease in FACT-G score compared to controls (p = 0.048) and also worsened on the LASA financial (p = 0.02).",
"At week 4 postintervention, women in the intervention group had statistically significant improvement in their FACT-G score, FACT-G physical well-being sub... | ABstRACT |
Please answer the following multiple-choice question:
Question: Consider the following argument: 'Gender-based differences appear to play a role in the early, but not late, response to a multidisciplinary intervention to improve QOL for patients with advanced cancer, early interventions can be tailored for each gender.... | 1C-P | [
"Men receiving the intervention had a smaller decrease in FACT-G score compared to controls (p = 0.048) and also worsened on the LASA financial (p = 0.02).",
"At week 27, the only gender difference was that intervention group men had more POMS anger-hostility (p = 0.009)."
] | ABstRACT |
Please answer the following multiple-choice question:
Question: Consider the following argument: 'Gender-based differences appear to play a role in the early, but not late, response to a multidisciplinary intervention to improve QOL for patients with advanced cancer, early interventions can be tailored for each gender.... | 1C-P | [
"Men receiving the intervention had a smaller decrease in FACT-G score compared to controls (p = 0.048) and also worsened on the LASA financial (p = 0.02).",
"By week 52, there were no statistically significant gender differences in any of the QOL measures."
] | ABstRACT |
Please answer the following multiple-choice question:
Question: Consider the following argument: 'Gender-based differences appear to play a role in the early, but not late, response to a multidisciplinary intervention to improve QOL for patients with advanced cancer, early interventions can be tailored for each gender.... | 1C-P | [
"At week 4 postintervention, women in the intervention group had statistically significant improvement in their FACT-G score, FACT-G physical well-being subscale, LASA fatigue, POMS total score, POMS fatigue-inertia subscale, and POMS confusion-bewilderment subscale (p < 0.05).",
"At week 27, the only gender diff... | ABstRACT |
Please answer the following multiple-choice question:
Question: Consider the following argument: 'Gender-based differences appear to play a role in the early, but not late, response to a multidisciplinary intervention to improve QOL for patients with advanced cancer, early interventions can be tailored for each gender.... | 1C-P | [
"At week 4 postintervention, women in the intervention group had statistically significant improvement in their FACT-G score, FACT-G physical well-being subscale, LASA fatigue, POMS total score, POMS fatigue-inertia subscale, and POMS confusion-bewilderment subscale (p < 0.05).",
"By week 52, there were no statis... | ABstRACT |
Please answer the following multiple-choice question:
Question: Consider the following argument: 'Gender-based differences appear to play a role in the early, but not late, response to a multidisciplinary intervention to improve QOL for patients with advanced cancer, early interventions can be tailored for each gender.... | 1C-P | [
"At week 27, the only gender difference was that intervention group men had more POMS anger-hostility (p = 0.009).",
"By week 52, there were no statistically significant gender differences in any of the QOL measures."
] | ABstRACT |
Please answer the following multiple-choice question:
Question: Consider the following argument: 'In the treatment group, 1 case suffered from chest distress, 3 cases suffered from acratia, and 4 cases suffered from pyrexia. DC/CIK treatment is a safe and effective method for maintenance therapy of advanced non-small c... | 1C-P | [
"In the treatment group, 1 case suffered from chest distress, 3 cases suffered from acratia, and 4 cases suffered from pyrexia.",
"Liver and kidney function and blood tests of the treatment group were within the normal range before and after treatment."
] | ABstRACT |
Please answer the following multiple-choice question:
Question: Consider the following argument: 'In the treatment group, 1 case suffered from chest distress, 3 cases suffered from acratia, and 4 cases suffered from pyrexia. DC/CIK treatment is a safe and effective method for maintenance therapy of advanced non-small c... | 1C-P | [
"In the treatment group, 1 case suffered from chest distress, 3 cases suffered from acratia, and 4 cases suffered from pyrexia.",
"DC/CIK treatment prolongs progression-free survival (3.20 months [95% CI, 2.94-3.50] vs 2.56 months [95% CI, 2.39-2.73]; P <0.05)."
] | ABstRACT |
Please answer the following multiple-choice question:
Question: Consider the following argument: 'In the treatment group, 1 case suffered from chest distress, 3 cases suffered from acratia, and 4 cases suffered from pyrexia. DC/CIK treatment is a safe and effective method for maintenance therapy of advanced non-small c... | 1C-P | [
"Liver and kidney function and blood tests of the treatment group were within the normal range before and after treatment.",
"DC/CIK treatment prolongs progression-free survival (3.20 months [95% CI, 2.94-3.50] vs 2.56 months [95% CI, 2.39-2.73]; P <0.05)."
] | ABstRACT |
Please answer the following multiple-choice question:
Question: Consider the following argument: 'In the treatment group, 1 case suffered from chest distress, 3 cases suffered from acratia, and 4 cases suffered from pyrexia. DC/CIK treatment is a safe and effective method for maintenance therapy of advanced non-small c... | 1C-P | [
"In the treatment group, 1 case suffered from chest distress, 3 cases suffered from acratia, and 4 cases suffered from pyrexia.",
"In the treatment group, the proportion of NK cells, T-cell subgroups CD3+, CD4+ and CD8+ had a significant change before and after treatment."
] | ABstRACT |
Please answer the following multiple-choice question:
Question: Consider the following argument: 'In the treatment group, 1 case suffered from chest distress, 3 cases suffered from acratia, and 4 cases suffered from pyrexia. DC/CIK treatment is a safe and effective method for maintenance therapy of advanced non-small c... | 1C-P | [
"In the treatment group, the proportion of NK cells, T-cell subgroups CD3+, CD4+ and CD8+ had a significant change before and after treatment.",
"DC/CIK treatment prolongs progression-free survival (3.20 months [95% CI, 2.94-3.50] vs 2.56 months [95% CI, 2.39-2.73]; P <0.05)."
] | ABstRACT |
Please answer the following multiple-choice question:
Question: Consider the following argument: 'Improvements in fatigue (p = 0.01), total quality of life plus fatigue (p = 0.04), and a composite physical functioning score (p = 0.01) at the 3-month follow-up were also found. The PEACH trial suggests that 8 weeks of su... | 1C-P | [
"Improvements in fatigue (p = 0.01), total quality of life plus fatigue (p = 0.04), and a composite physical functioning score (p = 0.01) at the 3-month follow-up were also found.",
"Self-reported physical activity increased in the exercise group (EG) compared to the usual care group at both 8-week (p = 0.01) and... | ABstRACT |
Please answer the following multiple-choice question:
Question: Consider the following argument: 'Improvements in fatigue (p = 0.01), total quality of life plus fatigue (p = 0.04), and a composite physical functioning score (p = 0.01) at the 3-month follow-up were also found. The PEACH trial suggests that 8 weeks of su... | 1C-P | [
"Improvements in fatigue (p = 0.01), total quality of life plus fatigue (p = 0.04), and a composite physical functioning score (p = 0.01) at the 3-month follow-up were also found.",
"Meaningful differences in aerobic fitness between the exercise and usual care groups at both the 8-week [mean 3.0 mL kg(-1) min(-1)... | ABstRACT |
Please answer the following multiple-choice question:
Question: Consider the following argument: 'Improvements in fatigue (p = 0.01), total quality of life plus fatigue (p = 0.04), and a composite physical functioning score (p = 0.01) at the 3-month follow-up were also found. The PEACH trial suggests that 8 weeks of su... | 1C-P | [
"Self-reported physical activity increased in the exercise group (EG) compared to the usual care group at both 8-week (p = 0.01) and 3-month follow-up (p = 0.03) and significant differences in favour of the EG were found for physical well-being at both the 8-week (p = 0.03) and 3-month follow-up (p = 0.04).",
"Me... | ABstRACT |
Please answer the following multiple-choice question:
Question: Consider the following argument: 'This may lead to reduced distress and fatigue, and consequently improved QoL of cancer survivors. In addition to physical activity, future interventions should target self-efficacy and mastery. The intervention was associa... | 1C-P | [
"The intervention was associated with increased physical activity (β = 0.46, 95% confidence interval (CI) = 0.14;0.59), general self-efficacy (β = 2.41, 95%CI = 0.35;4.73), and mastery (β = 1.75, 95%CI = 0.36;2.78).",
"The intervention had a borderline significant direct effect on reduced distress (β = -1.32, 95%... | ABstRACT |
Please answer the following multiple-choice question:
Question: Consider the following argument: 'This may lead to reduced distress and fatigue, and consequently improved QoL of cancer survivors. In addition to physical activity, future interventions should target self-efficacy and mastery. The intervention was associa... | 1C-P | [
"The intervention was associated with increased physical activity (β = 0.46, 95% confidence interval (CI) = 0.14;0.59), general self-efficacy (β = 2.41, 95%CI = 0.35;4.73), and mastery (β = 1.75, 95%CI = 0.36;2.78).",
"Reductions in fatigue (β = -1.33, 95%CI =-1.85;-0.83) and distress (β = -0.86, 95%CI = -1.25;-0... | ABstRACT |
Please answer the following multiple-choice question:
Question: Consider the following argument: 'This may lead to reduced distress and fatigue, and consequently improved QoL of cancer survivors. In addition to physical activity, future interventions should target self-efficacy and mastery. The intervention was associa... | 1C-P | [
"The intervention was associated with increased physical activity (β = 0.46, 95% confidence interval (CI) = 0.14;0.59), general self-efficacy (β = 2.41, 95%CI = 0.35;4.73), and mastery (β = 1.75, 95%CI = 0.36;2.78).",
"increased physical activity was directly associated with improved QoL (β = 3.37, 95%CI = 1.01;5... | ABstRACT |
Please answer the following multiple-choice question:
Question: Consider the following argument: 'This may lead to reduced distress and fatigue, and consequently improved QoL of cancer survivors. In addition to physical activity, future interventions should target self-efficacy and mastery. The intervention was associa... | 1C-P | [
"The intervention had a borderline significant direct effect on reduced distress (β = -1.32, 95%CI = -2.68;0.11), and a significant indirect effect via increased general self-efficacy and mastery (β = -1.06, 95%CI = -1.89;-0.38).",
"Reductions in fatigue (β = -1.33, 95%CI =-1.85;-0.83) and distress (β = -0.86, 95... | ABstRACT |
Please answer the following multiple-choice question:
Question: Consider the following argument: 'This may lead to reduced distress and fatigue, and consequently improved QoL of cancer survivors. In addition to physical activity, future interventions should target self-efficacy and mastery. The intervention was associa... | 1C-P | [
"The intervention had a borderline significant direct effect on reduced distress (β = -1.32, 95%CI = -2.68;0.11), and a significant indirect effect via increased general self-efficacy and mastery (β = -1.06, 95%CI = -1.89;-0.38).",
"increased physical activity was directly associated with improved QoL (β = 3.37, ... | ABstRACT |
Please answer the following multiple-choice question:
Question: Consider the following argument: 'This may lead to reduced distress and fatigue, and consequently improved QoL of cancer survivors. In addition to physical activity, future interventions should target self-efficacy and mastery. The intervention was associa... | 1C-P | [
"Reductions in fatigue (β = -1.33, 95%CI =-1.85;-0.83) and distress (β = -0.86, 95%CI = -1.25;-0.52) were associated with improved QoL.",
"increased physical activity was directly associated with improved QoL (β = 3.37, 95%CI = 1.01;5.54)."
] | ABstRACT |
Please answer the following multiple-choice question:
Question: Consider the following argument: 'Despite higher rates of some adverse effects (anemia, abdominal pain, constipation, fatigue) the overall toxicity profile of vinflunine was manageable. the overall toxicity profile of vinflunine was manageable. VFL may be ... | 1C-P | [
"No significant difference in patient benefit and QOL (Functional Assessment of Cancer Therapy-Lung).",
"ORR, stable disease, median OS, were 4.4% versus 5.5%, 36.0% versus 39.6%, 6.7 versus 7.2 months (HR, 0.973; 95% CI, 0.805 to 1.176), respectively."
] | ABstRACT |
Please answer the following multiple-choice question:
Question: Consider the following argument: 'Despite higher rates of some adverse effects (anemia, abdominal pain, constipation, fatigue) the overall toxicity profile of vinflunine was manageable. the overall toxicity profile of vinflunine was manageable. VFL may be ... | 1C-P | [
"No significant difference in patient benefit and QOL (Functional Assessment of Cancer Therapy-Lung).",
"Median PFS was 2.3 months for each arm (HR, 1.004; 95% CI, 0.841 to 1.199)."
] | ABstRACT |
Please answer the following multiple-choice question:
Question: Consider the following argument: 'Despite higher rates of some adverse effects (anemia, abdominal pain, constipation, fatigue) the overall toxicity profile of vinflunine was manageable. the overall toxicity profile of vinflunine was manageable. VFL may be ... | 1C-P | [
"ORR, stable disease, median OS, were 4.4% versus 5.5%, 36.0% versus 39.6%, 6.7 versus 7.2 months (HR, 0.973; 95% CI, 0.805 to 1.176), respectively.",
"Median PFS was 2.3 months for each arm (HR, 1.004; 95% CI, 0.841 to 1.199)."
] | ABstRACT |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.